GE HealthCare granted FDA nod for Precision DL to process medical imaging

• GE HealthCare (NASDAQ:GEHC) announced Tuesday that the FDA issued 510(k) clearance for Precision DL, a deep learning-based image processing software designed to enhance the quality of PET/CT imaging.
• Precision DL, an AI-based technology, is available on GE HealthCare's (GEHC) PET/CT system Omni Legend.
• It is the latest addition to the company's Effortless Recon DL portfolio, which leverages deep learning to improve image quality and enhance patient outcomes.
• "One of the main advantages of moving fully into the future of AI and deep learning is making state-of-the-art imaging accessible to more practices, across more care areas than ever before," remarked Jan Makela, CEO of GEHC's imaging unit.
• "Now we are proud to add Precision DL for PET/CT, enabling more precise and personalized care across healthcare systems' imaging departments."

More on GE HealthCare

• GE HealthCare to benefit from updated NCCN breast cancer guidelines
• GE HealthCare Technologies Is A Healthy Opportunity